Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 281 of 1,261

  1. US 11254640

    N-substituted indoles and other heterocycles for treating brain disorders

    The Regents of the University of California · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  2. US 11253686

    Swallowable drug delivery device and methods of drug delivery

    Rani Therapeutics, LLC · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  3. US 11253604

    Conjugate of methotrexate and peptide

    CAREGEN CO., LTD. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  4. US 11253591

    Combination of lenalidomide and polypeptide construct, and uses thereof

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  5. US 11253522

    Cancer treatment targeted to tumor adaptive responses to protein synthesis stress

    The Regents of the University of California · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  6. US 11253511

    Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)

    THE UNITED STATES OF AMERICA, as represented by th · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  7. US 11253509

    Methods of treatment for cystic fibrosis

    Vertex Pharmaceuticals Incorporated · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  8. US 11253557

    Therapeutic bacteriophage compositions

    Armata Pharmaceuticals, Inc. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  9. US 11253572

    Use of a VEGF antagonist to treat angiogenic eye disorders

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  10. US 11253506

    Compounds, compositions and methods for preventing and/or treating chlorine inhalation toxicity and/or injury

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  11. US 11253483

    Protease assisted native-protein delivery approach (PANDA)

    The Regents of the University of California · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  12. US 11253489

    Visual cycle modulators

    The United States Government as Represented by The Department of Veteran Affairs · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  13. US 11253494

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Jazz Pharmaceuticals Ireland Limited · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  14. US 11254940

    Inhibition of MAP4K4 through RNAi

    Phio Pharmaceuticals Corp. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  15. US 11255865

    Immunoassay for human erythroferrone

    The Regents of the University of California · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  16. US 11253508

    PPARy agonist for treatment of progressive supranuclear palsy

    Coherus BioSciences, Inc. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  17. US 11254655

    Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

    Theravance Biopharma R&D IP, LLC · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  18. US 11254652

    Crystalline forms of N-(4-(4-(cyclopropymethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide

    Agios Pharmaceuticals, Inc. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  19. US 11253504

    Compositions of a polyorthoester and an aprotic solvent

    Heron Therapeutics, Inc. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  20. US 11253445

    Oxidative hair color remover in tablet or pellet form

    Bright International, LLC · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  21. US 11253546

    Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20

    The Regents of the University of California · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  22. US 11254664

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  23. US 11254731

    Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A

    Takeda Pharmaceutical Company Limited · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  24. US 11254752

    Methods for treating cancer with bispecific anti-CD3xMUC16 antibodies and anti-PD-1 antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.